Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke "ATAMIS"

Recruiting

Phase Early 1 Results N/A

Summary of Purpose

The risk of early recurrence or progression of acute ischemic stroke is very high, even in patients treated with aspirin. The Chance study show that clopidogrel plus aspirin treatment reduced the risk of recurrent stroke in patients with transient ischemic attack (TIA) or minor ischemic stroke (NIHSS ≤ 3) within 24 hour onset and was not associated with increased hemorrhage events, compared with aspirin...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 April 2017.

1 Nov 2016 1 Aug 2016 1 Sep 2018 1 Dec 2018 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts